CTLA4 and arthritic joint disease: In combination with the cytotoxic T‐lymphocyte‐associated protein 4 immunoglobulin G (CTLA‐4‐Ig) DMARD in early‐stage arthritis, ATRA‐PLGA MP controlled disease and modified pain.